Dipyrone (Metamizole) Tablets

Analgesic, Anti-Inflammatory & Anti-Pyretic · Tablets / Injection · 500mg (tablets), 500mg/ml (injection)

Trade Information

Minimum Order Qty	1,000,000 tablets
Capacity	100 Million Tablets per month
Strength	500mg (tablets), 500mg/ml (injection)
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, IP compliant

Packing Options

Blister (Alu-Alu / Alu-PVC)
Strip pack
Ampoule (injection)
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Registered and widely used in many African, Latin American, and Asian markets. Restricted or not marketed in certain other countries. Supplied only to markets where registered and approved. Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Metamizole Sodium (Dipyrone)
Dosage Form	Tablets / Injection
Pack Size	10x10 (tablets), ampoule (injection) / Custom packing available
Storage	Store below 30°C in a dry place, protected from light
Shelf Life	24 months from date of manufacture

Description

Dipyrone (metamizole) is a potent pyrazolone analgesic and antipyretic widely used for moderate to severe pain and high fever in the many markets where it is registered. It has strong analgesic and antipyretic effects with some spasmolytic activity.

BioGalen manufactures Dipyrone in tablet and injection forms and supplies it only to markets where it is registered and approved for use, with CTD and ACTD dossiers and regulatory support for registration in those markets. Please confirm the regulatory status in your market when enquiring.

Mechanism of Action

Dipyrone (metamizole) is a pyrazolone-class agent. Its active metabolites are thought to inhibit prostaglandin synthesis and to act on central pain and temperature pathways, producing strong analgesic and antipyretic effects together with some spasmolytic (smooth-muscle relaxing) activity. Unlike the NSAIDs, it has only weak anti-inflammatory action, and its potency makes it useful for moderate to severe pain and high fever in the markets where it is registered.

Indications

Moderate to severe pain
Post-operative pain
Colicky (smooth-muscle spasm) pain
High fever not responding to other agents

Available Variants

Dipyrone (Metamizole) Tablets 500mg
Dipyrone (Metamizole) Injection

Frequently Asked Questions

What is Dipyrone (Metamizole) used for?

Dipyrone is a potent pyrazolone analgesic and antipyretic used for moderate to severe pain, including post-operative and colicky pain, and for high fever. It is widely used in many markets where it is registered.

Is Dipyrone available in all countries?

Dipyrone is registered and widely used in many African, Latin American, and Asian markets, but is restricted or not marketed in some others. BioGalen supplies Dipyrone only to markets where it is registered and approved for use.

What forms of Dipyrone does BioGalen manufacture?

BioGalen manufactures Dipyrone (metamizole) in tablet and injection forms, under WHO-GMP with CTD and ACTD dossiers available for registration where applicable.

Explore More

Interested in Dipyrone (Metamizole) Tablets?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form